Skip to main content

Table 1 Baseline characteristics of the patients, by aminoglycoside exposure

From: Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort

  All cases (N = 353)
  Amikacin (n = 51) Kanamycin (n = 302) P- value
Age (years): mean ± SD 35.69 ± 9.56 36.47 ± 11.57 P = 0.85
Body weight (kgs): mean ± SD 49.58 ± 8.83 50.76 ± 12.0 P = 0.77
Sex:    
 Male, n (%) 32 (63 %) 166 (55 %) P = 0.47
 Female, n (%) 19 (37 % 136 (45 %)  
HIV co-infection: n (%) 25 (49 %) 139 (46 %) P = 0.53
DR-TB site:    
 Katutura 0 46 (15 %)  
 Oshakati 1 (2 %) 65 (22 %) P < 0.001
 Rundu 0 67 (22 %)  
 Walvis Bay 50 (98 %) 124 (41 %)  
Reporting period:    
 2004–2009, n (%) 45 (88 %) 48 (16 %) P < 0.001
 2010–2011, n (%) 4 (8 %) 61 (20 %)  
 2012, n (%) 1 (2 %) 112 (37 %)  
 2013–2014, n (%) 0 80 (27 %)  
 Missing, n (%) 1 (2 %) 1 (0.3 %)  
  1. SD standard deviation, IQR interquartile range, HIV Human immunodeficiency virus